BIOSIG TECHNOLOGIES INC | 10-Q: Q3 2024 Earnings Report
BioSig Regains Compliance With Nasdaq's Minimum Bid Price Requirement
Express News | BioSig Regains Compliance With Nasdaq’s Minimum Bid Price Requirement
12 Health Care Stocks Moving In Monday's After-Market Session
Sudden Impact | biosig technologies soared more than 60% in pre-market trading, approved to continue listing.
Medical technology company BioSig Technologies announced yesterday that its stocks resumed trading on the nasdaq capital markets exchange and soared before the market opened.
BioSig Technologies' Common Stock To Resume Trading On The Nasdaq Exchange, Wednesday, October 23, 2024 After Its Appeal Was Granted An Extension Until March 7, 2025